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SOME NEW Rh ANTIGENS Rh43 TO Rh47 
Peter D. Issitt, Nancy S. Gutgsell 
Introduction 
In 1962, Rosenfield et al sup(1) reviewed the serology of the Rh blood group 
system and introduced a numerical terminology. Numbers for the anti- 
gens Rhl to Rh21 were assigned in the text of that report, Rh22 to Rh25 
were listed in an addendum printed as part of the paper. A number of 
reports of new Rh antigens were reviewed by Allen and Rosenfield sup(2) in 
1972; in that paper the numbers Rh26 to Rh33 were assigned. In a later 
review, sup(3) this time on Rh genetics, Rh34 was named. The term Rh35 seems 
first to have been used in two textbooks published in 1975. sup(4,5) When 
we sup(6) described the first examples of anti-Rh39 in 1979, we took the op- 
portunity to update the numerical Rh terminology from Rh36 to Rh39. 
The next three Rh antigens to be discovered were assigned numbers by 
the authors first describing them. Rh40 was named by Lewis et al sup(7) when 
they showed that the low incidence antigen Tar, which they had 
described earlier, sup(8) belongs in the Rh system. Rh40 has now been shown 
to be the marker antigen for Category VII red cells, sup(9) a new class in the 
classification scheme of Tippett and Sanger, sup(10) for the D + red cells of 
persons who can form allo-anti-D. The only known example of anti-Rh41 
was named by Svoboda et al sup(11) in the paper in which that antibody was 
described. Similarly, in the abstract in which the only example of the 
definitive antibody was reported, sup(12) the antigen recognized was named 
Rh42. Since 1982, responsibility for the assignment of numbers for new 
Rh antigens has rested with a Working Party on Terminology for Red 
Cell Surface Antigens of the International Society for Blood Transfusion. 
Following meetings of the working party in Budapest in 1982 and 
Munich in 1984, a report was published sup(13) that included assignment of 
the terms Rh43, Rh44, and Rh45. At the 1986 meeting of the working 
party in Sydney, the terms Rh46 and Rh47 were assigned. The purpose 
of this review is to describe briefly the places of Rh43 to Rh47 in the 
Rh system. 
Rh43(Crawford) 
In 1980, Cobb sup(14) published an abstract describing a hitherto unrecog- 
nized low-incidence antigen, Crawford or Craw. Although the abstract 
states that the gene that encodes the new antigen segregated indepen- 
dently of Rh in a large family studied, reexamination of the pedigree 
showed that not to be the case. As far as this author is aware, the evidence 
that associates Craw with the Rh system is somewhat circumstantial and 
the association has yet to be proved at the genetic level. The first piece 
*It should be noted that the references cited are to papers in which the antigens were 
assigned numbers and not, with the exception of Rh39, to papers in which discovery 
of the antigens was described 
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of evidence that suggested that Craw might be part 
of the Rh system was that two lots of a licensed anti- 
D typing reagent gave positive reactions with several 
known D"- samples by IAT. The responsible anti- 
body (anti-Craw) in the anti-D was isolated and the 
antigen defined was shown to be present in a little 
fewer than one in 1,000 blacks in the southeastern 
United States. sup(14) The second piece of evidence to 
associate Craw with the Rh system was that many but 
not all Craw + samples found came from persons who 
had inherited r sup(’s) (J. J. Moulds, personal communica- 
tion, and S. L. Wilkinson and P. D. Issitt, unpublished 
observations, 1980 and 1981). No consistent pattern 
of V and VS status on Craw + red cells could be seen. 
In spite of this somewhat tenuous evidence, Craw was 
assigned the number Rh43 in 1985. sup(13) 
Rh17(Hr sub(o)), Rh18)(Hr), and Rh34 
Although the three antigens listed above are not 
new, mention of some of their characteristics is neces- 
sary before Rh44, Rh46, and Rh47 can be described. 
As early as 1958, Men and Corcoran sup(15) recognized that 
when D-deletion homozygotes become immunized, 
the most potent antibody that they make is often one 
directed against Hr sub(o), an antigen present on all red 
cells of "common" Rh phenotype, eg, R sub(1),R sub(1), R sub(2)R sub(2), rr. sup(16) 
Sequential adsorption-elution steps can be used to 
render anti-Hr sub(o), free of anti-e, anti-c, etc. When the 
blood of Mrs. Shabalala was studied by Shapiro, sup(17) it 
was shown that her red cells would adsorb anti-Hr sub(o), 
from the sera of immunized D-deletion persons but 
that they left unadsorbed a second antibody that also 
reacted with all "common" Rh phenotype red cells. 
The red cells of Shabalala were said to be Hr sub(o) + , 
Hr-; the antibody not adsorbed by her red cells was 
called anti-Hr (Mrs. Shabalala herself made anti- 
Hr/hr sup(s).) In 1979, when we sup(6) restudied the antibody 
made by Mrs. Bastiaan, sup(18) we showed that D-deletion 
red cells are Rh:-34, in addition to being Rh:-17,-18. 
For a number of years, it seemed that the genes D--, 
Dc-, and DC sup(w)- all fail to encode Rh17, Rh18, and 
Rh34, and that the immune response in individuals 
homozygous for those genes involved production of 
anti-Hr sub(o), -Hr, and - a 3 4  in variable amounts, and 
sometimes the production of separable antibodies 
directed against C, c, E, e, f, hrs, etc, as well. As will 
become apparent from the descriptions of Rh44, 
Rh46, and Rh47, the situation is not even that simple! 
Rh44(Nou) 
In 1969, Salmon et al sup(19) described an individual 
(Madame Nou) who was homozygous for a new D- 
deletion gene, D sup(IV)(C)-. It was shown that the gene 
makes D, Go sup(a), and a weak form of C. In 1981, 
Perrier et al sup(20) described a study that included tests 
against the red cells of Madame Nou that suggested 
that some antibodies made by D-deletion homo- 
zygotes might recognize a high-frequency antigen or 
antigens in addition to Hr sub(o), Hr, and Rh34. Later in 
the same year, Habihi et al sup(21) published the definitive 
study. It was shown that although D sup(IV)(C)- does not 
make Hr sub(o) or Hr, it does make a very common anti- 
gen, the antibody to which is present in a minority 
of sera from immunized D-deletion homozygotes. 
Table 1 shows the results of the tests described by 
Habibi et al sup(21) in which they used antibodies made by 
D-deletion individuals and red cells of D-deletion and 
Rh,., phenotypes. The antibodies were adsorbed 
onto and eluted from R sub(2)R sub(2) red cells to free them of 
separable anti-e. They were then used in titration 
studies against the red cells of ten persons with com- 
mon Rh phenotypes, and four who were D--/D--, 
two who were Dc-/Dc, Madame Nou (D sup(IV)(C)-/ 
(D sup(IV)(C)-, and one who was Rh,,. As the results in 
Table 1 show, five of the eluates contained only anti- 
Hr sub(o)/Hr, since they reacted with all common pheno- 
type red cells hut not with those of D-deletion or 
Rh,,, phenotypes. The fact that the red cells of 
Madame Nou failed to react with these antibodies con- 
firmed that (D sup(IV)(C)-/ does not make Hr sub(o) or Hr. The 
two eluates that did react with the red cells of Madame 
Nou (numbers 1 and 4 in Table 1) clearly contained 
another antibody defining an antigen made by 
(D sup(IV)(C)-/ but not by the other D-deletion genes. Since 
it was known by then that (D sup(IV)(C)-/ makes Go sup(a) 
(Rh30), Rh33, and Rh45 (for references, see next sec- 
tion) it was possible that the additional antibody was 
directed against one of those antigens. Adsorption 
studies quickly eliminated that possibility. The anti- 
body activity in both eluates was adsorbed to exhaus- 
tion using red cells of common R h  phenotypes that 
were Rh:-30,-33,-45. The same eluates were 
adsorbed with (D sup(IV)(C)-/(D sup(IV)(C)- red cells until they no 
Table 1. Titer scores of eluates from R sub(2)R sub(2) red 
cells from antibodies made by D-deletion 
homozygotes in tests against red cells of deletion 
phenotypes (from Habibi et al) sup(21) 
Test red Antibody made by 
cells (D sup(IV)(C)-/ 
D--/D-- Dc-/Dc- (D sup(IV)(C)-/ 
I 2  3  4 5 6 7 
Common 
Rh pheno- 
types 65-72 8-13 21-41 34-42 35-47 26-35 34-39 
(10 samples) 
Dc-/Dc- 0 0 0 0 0 0 0 
Dc-/Dc- 0 0 0 0 0 0 0 
(D sup(IV)(C)-/ 
(D sup(IV)(C)- 5 5  0 0 13 0 0 0 
D--/ID-- 0 0 0 0 0 0 0 
D--/D-- o 0 o 0 0 0 0 
D--/D-- 0 0 0 0 0 0 0 
D--/D-- 0 0 0 0 0 0 0 
Rh sub(null) 0  0  0 0 0 0 0 
longer reacted with those cells. After absorption with 
the D sup(IV)(C)-/D sup(IV)(C)- red cells, the eluates reacted with 
all cells of common Rh phenotype, showing that the 
anti-Hr sub(o)/Hr and additional antibody in the eluates 
were separable. Thus it was clear that the new antigen, 
Nou (later given the designation Rh44), sup(13) is made by 
all common Rh genes (red cells of common Rh pheno- 
types adsorbed the anti-Hr sub(o)/Hr and anti-Rh44 
activity) sup(l3) and by D sup(IV)(C)- (the red cells of Madame 
Nou adsorbed anti-Rh44 but not anti-Hr sub(o),/Hr), but not 
by D-- or Dc- (red cells from persons with those 
genes were non-reactive with the two eluates that con- 
tained anti-Rh44), Table 1. 
Later in this review, the probable antithetical rela- 
tionship between Rh46 and Rh32 will be described. 
In addition, it is possible that two new antibodies cur- 
rently under study (see summary) define antigens anti- 
thetical to Rh33 and Rh9(C sup(x)). For this reason, it is 
important to appreciate that Rh44 cannot be antitheti- 
cal to any low-incidence antigen (Go sup(a), Rh33, Rh45) 
made by (D sup(IV)(C)-. Instead, Rh44 is encoded by all 
common Rh genes and by (D sup(IV)(C)-. Madame Nou is 
immunized and her serum contains at least anti-Hr, 
and/or anti-Hr (see Table 1). G. L. Daniels (personal 
communication 1986) has pointed out that her serum 
might also contain an antibody that defines an as yet 
unrecognized, low-incidence antithetical partner to 
Rh44. Studies to investigate such a possibility have not 
yet been reported. 
Rh4 5 (Riv) 
The first known exampleZZ of anti-Riv (later assigned 
the designation anti-Rh45) sup(13) caused mild hemolytic 
disease of the newborn. The antibody was made by 
a Cuban woman who, like her Cuban husband, came 
from a family with known black admixture. When 
Mrs. Riv was delivered of her second child, it was 
found that the red cells of the infant had a positive 
DAT. The maternal serum and an eluate made from 
the cord blood red cells contained an antibody that 
reacted strongly with the red cells of the infant's father 
but not with other samples (the maternal anti-Le" 
played no role in the HDN and will not be considered 
further). Rh  phenotyping tests on the red cells of the 
mother, her husband, and the infant at first appeared 
to exclude the husband from paternity. Based on the 
most simple interpretation of such tests, the trio ap- 
peared to be R sup(o)r (mother), R sup(1W) R sup(1) (husband), R sup(o)r 
(child). However, there was no other evidence to ex- 
clude the husband from paternity, and the fact that 
his red cells carried the same low-incidence antigen 
as those of the child, as defined by the antibody in 
the maternal serum, made an exclusion highly unlike- 
ly. Additional phenotyping studies yielded the results 
shown in Table 2. As can be seen, the father had 
passed an Rh gene making Go sup(a) and Rh33, and a very 
weak form of C, to his child. The child did not in- 
herit the paternal gene that encodes C sup(w). The lower 
portion of Table 2 shows a genetic interpretation of 
the family. 
Tests on the maternal serum showed the presence 
of anti-Go sup(a) and the antibody defining Rh45. Separa- 
tion of anti-Go sup(a) from anti-Rh45 was accomplished 
by adsorption with Go(a+), Rh:-45 red cells. The 
maternal serum did not contain anti-C sup(w) or anti- 
Rh33; later studies showed that the couple's first child 
had also inherited the paternal D sup(IV)(C)- that encodes 
Go sup(a), Rh33, and Rh45, but not C sup(w). Tests on the 
eluate made from the cord blood red cells showed the 
presence of strong anti-Rh45 (4 + IAT reactions with 
all red cells from persons known to have inherited 
D sup(IV)(C)-) and weak anti-Go sup(a) (1 + IAT reactions with 
Go(a +), Rh-45 red cells). Thus, it seemed that the 
mild HDN (the infant recovered without transfusion) 
was caused predominantly by anti-Rh45, with anti- 
Go sup(a) playing only a minor role despite the fact that 
both antibodies gave 4 +  IAT reactions when the 
maternal serum was tested. 
A number of red cell samples from persons who had 
inherited D sup(IV)(C)- were available for testing. The 
maternal serum was adsorbed free of anti-Go" and 
was then shown to react strongly with the red cells 
of Madame Nou (D sup(IV)(C)-/D sup(IV)(C)-) and with those of 
individuals genetically D sup(IV)(C)-/r D sup(IV)(C)-/R sup(2) and 
During this study sup(22) and those in Paris on the blood 
of Madame Nou, sup(20,21) it was noticed that D sup(IV)(C)- en- 
codes Rh33 in addition to Go sup(a)(Rh30) and Rh45(Riv). 
The Paris workers (C. Salmon, personal communica- 
D sup(IV)(C)-/R sup(o) 
Table 2. Extended Rh phenotyping studies on the 
red cells of members of the Riv family* 
Family member Rh phenotype 
Mrs. A.R. (Mother) D + ,  C-, c + ,  E-, e + ,  C sup(w-), Go(a-), 
Rh:-33,-45. Lack of C proved by 
adsorption-elution studies. 
D + ,  C + ,  c-, E-, e + ,  C sup(w)+, Co(a+), 
Rh:33. Positive for the new Rh anti- 
gen defined by the maternal antibody, 
ie, Rh:45. Lack of c proved in 
adsorption-elution studies. 
D + , C- in direct tests, c + , E-, e + , 
C sup(w)-, Go(a+), Rh:33,45. Presence of 
weak C and lack of C sup(w) proved in 
adsorption-elution studies. Presence of 
Rh45 confirmed by recovery of anti- 
Rh45 from the DAT + cord blood red 
cells. 
Mr. S.R. (Father) 
A.R. (Infant) 
Genetic interpretations of above phenotypes 
Mrs. A.R. (Mother) R sup(o)/r 
Mr. S.R. (Father) R sup(1w)/D sup(IV)(C)- 
A.R. (Infant) R sup(o)/D sup(IV)(C)- 
'Note: Some of these data included in poster but not 
abstract of reference 22. 
3 
tion 1982) found that red cells from persons with 
D sup(IV)(C)- also reacted with a serum used there that 
was thought to contain only anti-Rh32. In Cincinnati 
(S. L. Wilkinson and P. D. Issitt, unpublished obser- 
vations 1982) and in London (P. Tippett and C. Lomas, 
personal communication 1982) those red cells were 
non-reactive with all available examples of anti-Rh32. 
This discrepancy, which may indicate the presence 
of yet another low-incidence antigen made by 
D sup(IV)(C)- has not yet been resolved. 
The gene D sup(IV)(C)- is thus unique in that it encodes 
at least three rare R h  antigens, Go", Rh33, and Rh45. 
The red cells of the father of infant Riv are also unique 
in that they carry C sup(w) (made by his R sup(1W) gene) in addi- 
tion to Go sup(a), Rh33, and Rh45. 
Rh46(Sec) 
The R sup(N) gene was first described by Rosenfield et 
al sup(23) in the now famous Charlie By. family. The gene 
encodes such a weak form of C that the presence of 
that antigen can be overlooked if the pc on on whose 
red cells it is present has a paired R' gene. Some 
years after R sup(N) had been described, Chown et al sup(24,25) 
reported that, in addition to its other actions, R sup(N) en- 
codes the low-incidence antigen Rh32. There are now 
a fair number of antibodies known, that have been 
made by individuals who seem to be genetically 
R sup(N)R sup(N); what may have been the first recognized ex- 
ample (Sec) was mentioned briefly by Chown et al sup(26) 
in 1972. The examples most fully studied in our 
laboratory were in the sera Coul (kindly supplied by 
Dr. Salmon from Paris) M-J.F. (kindly supplied by Ms. 
Mary Anne McDowell from Columbus, Ohio) and V.Q. 
(kindly supplied by Mr. W. Michael Tregallas from 
Scottsdale, Arizona). At the 1986 Sydney meeting of 
the ISBT working party, Dr. Phillipe Rouger mention- 
ed that the Paris workers have a paper in press, 
describing many examples of this antibody; these 
authors have not yet seen that paper. 
The antibody, that was named anti-Rh46 in Sydney 
reacts with all red cells of common Rh phenotype, 
and with many of unusual phenotype (Shabalala-type; 
Dc(e)/Dc(e), Rh:33; DCXe/DCXe; etc). It does not 
react with D-deletion or Rh sub(null) red cells or with those 
from persons homozygous for RN. Anti-Rh46 differs 
from anti-Hr sub(o)/Hr by failing to react with the red cells 
of R sup(N) homozygotes that appear to be Hr, + , Hr + . 
The authors presume, but do not know for sure, that 
differentiation between anti-Rh44 and anti-Rh46 has 
been made on the basis of adsorption studies. If R sup(N) 
encodes Hr,, Hr and Rh44, it would be expected 
that red cells from an R sup(N) homozygote would adsorb 
to exhaustion a serum from an immunized D-deletion 
individual that contained all three antibodies (see sec- 
tion on Rh44 and Table 1). The red cells of R sup(N) 
homozygotes do not, of course, adsorb anti-Rh46. 
Perhaps the most exciting aspect of Rh46 is the 
possibility that it may have some sort of antithetical 
relationship to Rh32. R sup(N) encodes the rare antigen 
Rh32; persons who are genetically R sup(N)R sup(N) have red 
cells that are Rh:32,-46. Although there is no com- 
plete agreement as yet about the exact nature of the 
red cell membrane structure that carries the R h  anti- 
gens, there is some good evidence sup(27-33) that the com- 
ponent is (are) a non-glycosylated polypeptide(s). It 
is not at all unreasonable to suppose that the same 
amino acid substitution(s) that give(s) rise to the rare 
antigen Rh32, result(s) ig the absence of Rh46. Individ- 
uals homozygous for R sup(N) would then have Rh32 on 
both polypeptides on which that antigen is carried, 
and would have Rh:-46 red cells. When exposed to 
Rh:46 red cells by transfusion or pregnancy, such in- 
dividuals might be expected to mount an immune 
response to that antigen. It seems that this describes 
exactly the circumstances in which anti-Rh46 has been 
made. It is also entirely possible that the same amino 
acid substitution(s) that result(s) in the presence of 
Rh32 cause(s) a steric rearrangement of the polypep- 
tide so that C and e become less available to complex 
with their antibodies. A characteristic of the presence 
of R sup(N) is that the individual's red cells carry reduced 
levels of e and difficult-to-detect C if the paired gene 
does not make those antigens. As mentioned in the 
summary, it is possible that two other antibodies cur- 
rently under study are to Rh33 and Rh9(C sup(x)) what 
anti-Rh46 is to Rh32. 
In considering possible antithetical relationships in 
the Rh system, it must be remembered that such rela- 
tionships are not totally straightforward all the time. 
When common Rh genes are considered, C and c, and 
E and e behave as pairs of alleles so that C and c, and 
E and e appear to be antithetical pairs of antigens. Ex- 
ceptions are seen. The genes D-- and D•• do not 
make C, c, E, or e. The genes Dc-, DC sup(W-) and 
D sup(IV)(C)- do not make E or e. The gene r sup(’s) makes both 
c and some C or C sup(G). For a review of different inter- 
pretations, see reference 34. 
Rh4 7(Dav) 
The antigenic products of D-- and D•• are similar 
enough that before 1978 it was difficult to distinguish 
between presence of the genes. This problem was 
overcome when Contreras et al sup(35,36) showed that D•• 
encodes the low-incidence antigen Rh37(Evans), while 
D-- does not. In 1982, Daniels37 showed that D•• 
is somewhat like D sup(IV)(C)- in that it makes an antigen 
of very high incidence that is not made by D-- or 
Dc-. Table 3 lists some of the results presented by 
DanieIs. sup(37,38) As can be seen, of 25 sera from im- 
munized D-deletion individuals, each of which con- 
tained anti-Hr, and/or anti-Hr (reactions with red 
cells of common phenotypes), 2 1 failed to react with 
D-deletion and D • • /D • • red cells. This of course con- 
firmed that D• • does not make Hr, or Hr. The other 
four sera, one each from immunized D--/D--, D--/ 
--- , Dc-/Dc-, and DC sup(w-)/DC sup(w-) individuals, reacted 
4 
Table 3. Reactions of sera from immunized 
D-deletion homozygotes in tests against red cells 
of deleted Rh phenotypes (from Daniel) sup(37) 
Number of Test red cells 
Phenotype of sera giving 
antibody- these Normal Rh 
maker reactions phenotype D--/D-- D• •/D• ' Rh., 
D--/D-- 15 + 0 0 0 
D--/D-- 1 + 0 + 0 
D--/--- 1 + 0 + 0 
Dc-/Dc- 2 + 0 0 0 
Dc-/Dc- 1 + 0 + 0 
DC sup(W)-/DC sup(W)- 2 + 0 0 0 
DC sup(W)-/DC sup(W)- 1 + 0 + 0 
D sup(IV) (C)-/ 
D sup(IV) (C)-/ 1 + 0 0 0 
D••/D•• 1 + 0 0 0 
with all red cells of common phenotype and with the 
D••/D• but not with other D-deletion, nor with 
Rh sub(null) red cells. It was apparent that these sera con- 
tained additional antibody activity that defined an anti- 
gen present on D• /D•• but not on D--/D-- red cells. 
Since D•• encodes Rh37, it was necessary to show 
that the additional antibody was not anti-Rh37. This 
was accomplished by adsorption studies. Red cells of 
common Rh phenotypes that were Rh:-37 adsorbed 
all antibody activity from the sera. D•• /D•• red cells 
adsorbed all activity for red cells of that phenotype 
and left the anti-Hr sub(o),/Hr unadsorbed. In other words, 
the newly defined antigen Dav, later assigned the term 
Rh47 (ISBT working party, Sydney 1986, report not 
yet published), is encoded by all common Rh genes 
(red cells of common phenotypes adsorb anti-Hr sub(o),/Hr 
and anti-Rh47) and by D•• (red cells from an individ- 
ual homozygous for that gene adsorb anti-Rh47 but 
not anti-Hr sub(o)/Hr). Rh47 is not made by D-- (red cells 
from individuals homozygous for that gene are non- 
reactive with the sera that contain anti-Rh47) and 
probably not by Dc- or DC sup(w-) (one example each of 
anti-Rh47 made by Dc- and DC sup(w-) homozygotes). As 
expected, Rh47 is not present on red cells. 
Daniels37 also showed that a serum that contained anti- 
Hr, and/or anti-Hr and anti-Rh47 still reacted with 
D sup(IV)(C)-/D sup(IV)(C)- red cells after it had been adsorbed 
with D• •/D•• red cells until it no longer reacted with 
such cells. This showed that anti-Rh47 was different 
from anti-Rh44 (ie, anti-Rh47 removed, serum still 
reactive with Rh:44 (Nou) red cells). In the report 
Daniels says that "anti-Nou" (now anti-Rh44) "may 
contain anti-Dav" (now anti-Rh47). The above test 
seems to suggest that the serum that contained anti- 
Hr, and/or anti-Hr and anti-Rh47 also contained anti- 
Rh44 (anti-Nou). That is, the serum rendered free of 
anti-Rh47 by adsorption with D• •/D•• red cells still 
reacted with Rh:44 (D sup(IV)(C)-/D sub(IV)(C)-) cells, although 
D sup(IV)(C)- is known not to make Hr, or Hr. 
The study of Daniels37 also showed that 
Rh37@vans) and Rh47(Dav) are not antithetical since 
both are encoded by D•• . G. L. Daniels (personal com- 
munication, 1986) has pointed out that the serum of 
an immunized D•• homozygote may contain an as yet 
unrecognized antibody to a low incidence antithetical 
partner of Rh47, in addition to its known anti-Hr, 
and/or anti-Hr content. 
Other Possible "New" Rh Antigens 
As described, Rh44, Rh45, Rh46, and Rh47 seem 
to be established as distinct Rh system antigens; more 
work is required for Rh43 to achieve a similar status. 
We are aware that a number of additional sera that 
may contain antibodies to still more "new" Rh anti- 
gens are currently under intense scrutiny in different 
laboratories around the world. Our own current in- 
vestigations involve a number of such sera. We are 
studying three examples of an antibody that may 
define a very common antigen that bears an antitheti- 
cal relationship to Rh33, similar to the relationship 
between Rh46 and Rh32. In addition, we are investi- 
gating possible heterogeneities of both anti-Rh29 and 
the D--/D-- phenotype. The antibody made by C.M., 
as described in an abstract by Mougey et al, sup(39) might 
recognize an antithetical partner of Rh9(C sup(x)). We 
have also heard of one other low-incidence antigen 
that may be a part of the Rh system. As can be seen 
from the above descriptions of Rh44, Rh46, and Rh47, 
it is now very difficult to be certain that an apparently 
new antibody to a very common Rh antigen is differ- 
ent from those directed against Hr,, Hr, Rh29, Rh34, 
Rh39, Rh44, Rh46, and Rh47, already characterized. 
Careful adsorption studies are essential and even then 
the adsorbed sera must be tested against very rare, red 
cell samples, such as those from D sup(IV)(C)-, D•• and R sup(N) 
homozygotes. If work currently in progress shows that 
some of these antibodies do indeed define additional 
Rh antigens, another review similar to this one will 
be prepared. 
Finally, in addition to the assignment of new Rh 
numerical terms, two numbers have been declared ob- 
solete. The ISBT working party has agreed (Sydney, 
1986) that because the genes that encode their produc- 
tion are known not to reside at the Rh locus, the anti- 
gens previously called Rh25(LW) and Rh38(Duclos) 
will not be considered part of the Rh system. The 
numbers Rh25 and Rh38 will be retired and will not 
be reassigned to new antigens. Their re-use for dif- 
ferent antigens would obviously cause confusion. 
Since their production is also controlled by 
genesdo sup(40-42) at a locus independent of Rh, the antigens 
LW sup(b)(Ne sup(a)) and LW sup(ah) will not receive Rh  numbers. 
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STIMULATION OF ANTIBODY 
STUDIES 
Susan S. Esty, Tracy Wahl, Julie Zawisza, 
Delores Mallory, Richard J. Davey 
Abstract 
The survival of red blood cells (RBCs) radiolabeled 
with sup(51)chromium (sup(51)Cr) is a reliable method for pre- 
dicting transfusion compatibility. Approximately 1 .0 
ml of sup(51)Cr tagged RBCs is infused into the patient and 
samples are drawn at predetermined intervals post in- 
fusion to determine RBC survival. Red cells used for 
the study are usually incompatible with the patient's 
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